Hoth Therapeutics, Inc. (HOTH) Dividend History

Hoth Therapeutics, Inc. is a biopharmaceutical company focused on developing targeted therapies for unmet medical needs. It emphasizes research in areas such as dermatology and neurological disorders, aiming to advance innovative treatments through strategic collaborations and proprietary platforms.

590 Madison Avenue, New York, NY, 10022
Phone: (646)756-2997
Website:

Dividend History

Hoth Therapeutics, Inc. currently does not pay dividends

Company News

  • Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.

    Zacks Investment Research
    Featured Companies: ACET ADMA FGEN
  • Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.70 million. Peraso shares tumbled 23.3% to $1.32 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Ontrak, Inc. (NASDAQ: OTRK) shares climbed 197.8% to $0.5660 ahead of the company's presentation at the 36th Annual Roth Conference. Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) gained 97.3% to $20.99 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21. SCWorx Corp. (NASDAQ: WORX) gained 74% to $3.22. Spire Global, Inc. (NYSE: SPIR) climbed 50.7% to $18.50 after announcing a collaboration with NVIDIA to advance AI-driven weather prediction. Enveric Biosciences, Inc (NASDAQ: ENVB) shares climbed 43.6% to $1.5801 after the company announced that it signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases. Zoomcar Holdings, Inc. (NASDAQ: ZCAR) rose 33.1% to $1.57 after the company announced that it partnered with EaseMyTrip to integrate its cars within the travel platform. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 32% to $1.51 after the company announced pre-clinical research showcasing the potential of HT-ALZ in Alzheimer's disease. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 27.2% to $16.09. The company announced a $90 million private placement financing and provided pipeline updates. National CineMedia, Inc. (NASDAQ: NCMI) gained 25.5% to $5.30 after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. The company said it sees first-quarter total revenue of $34.5 million to $35.5 million. Alignment Healthcare, Inc. (NASDAQ: ALHC) gained 17.7% to $5.50. Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose 15% to $43.63 ...

    Benzinga
  • EF Hutton has decided to maintain its Buy rating of Hoth Therapeutics (NASDAQ:HOTH) and lower its price target from $12.00 to $7.50. Shares of Hoth Therapeutics are trading down 11.41% over the last 24 hours, at $1.70 per share. A move to $7.50 would account for a 340.92% increase from the current share price. About Hoth Therapeutics Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform ...Full story available on Benzinga.com

    Benzinga
  • Within the last quarter, Hoth Therapeutics (NASDAQ:HOTH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 1 1 0 0 0 In the last 3 months, 5 analysts have offered 12-month price targets for Hoth Therapeutics. The company has an average price target of $10.4 with a high of $14.00 and a low of $5.00. Below is a summary of how these 5 analysts rated Hoth Therapeutics over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the ...Full story available on Benzinga.com

    Benzinga
  • Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for political campaigns. Farmer Bros. Co. (NASDAQ: FARM) surged 56.4% to $3.02. Treehouse Foods inked a deal with Farmer Brothers to acquire certain assets for around $100 million, subject to customary purchase price adjustments. Yext, Inc. (NASDAQ: YEXT) shares climbed 32.8% to $12.74 after the company reported better-than-expected first-quarter results and issued strong FY24 forecast. Stitch Fix, Inc. (NASDAQ: SFIX) shares climbed 31.5% to $4.84 as the company reported better-than-expected results for its third quarter. Chijet Motor Company, Inc. (NASDAQ: CJET) gained 25.7% to $5.28 after dropping around 29% on Tuesday. Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) rose 23.6% to $41.73 following upbeat quarterly earnings. The company inked a 15-store deal with the Malpani Group in India and a 5-store agreement with the NightOwl Entertainment Group in Australia. Aurora Innovation, Inc. (NASDAQ: AUR) gained 20% to $1.8250. Canaccord Genuity initiated coverage on Aurora Innovation with a Buy rating and announced a price target of $5. Hyzon Motors Inc. (NASDAQ: HYZN) rose 19.8% to $0.7383. Hyzon Motors and Performance Food Group entered into an agreement for five fuel-cell electric vehicles (FCEV). Affirm Holdings, Inc. (NASDAQ: AFRM) surged 19.4% to $18.90 after Amazon added Affirm's Adaptive Checkout as a payment option at checkout. Diversified Healthcare Trust (NASDAQ: DHC) rose 17.2% to $2.32. Diversified Healthcare Trust Director Adam D Portnoy acquired a total 5,566,644 shares an average price of $1.77. Wejo Group Limited (NASDAQ: WEJO) shares gained 16.3% to $0.0699 after dropping 29% on Tuesday. Wejo Group recently said it is evaluating whether to file ancillary insolvency proceedings for the company and other units in other jurisdictions, including the US. Novonix Limited (NASDAQ: NVX) rose 15.8% to $3.07. AVL Test Systems, Inc. announced it has finalized a Sales and ...

    Benzinga
Dividend data last updated 06/07/2025 18:46:20 UTC